已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Single-Cell Sequencing and Immune Function Assays of Peripheral Blood Samples Demonstrate Positive Responses of an Inactivated SARS-CoV-2 Vaccine

外周血单个核细胞 免疫系统 抗体 接种疫苗 病毒学 免疫学 血液取样 医学 冠状病毒 2019年冠状病毒病(COVID-19) 生物 内科学 体外 传染病(医学专业) 疾病 生物化学
作者
Haoran Zhang,Yaling Hu,Zhujun Jiang,Ningning Shi,Haishuang Lin,Yudong Liu,Hui Wang,Yingmei Feng,Xing Meng,Shunjia Zhang,Li Su,Zhetao Zheng,Liangzhen Dong,Qiang Gao,Qing Xia
出处
期刊:Social Science Research Network [RELX Group (Netherlands)]
被引量:9
标识
DOI:10.2139/ssrn.3774153
摘要

Background: Safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently needed to halt the spread of coronavirus disease 2019 (COVID-19) pandemic. As a promising inactivated SARS-CoV-2 vaccine, CoronaVac (developed by Sinovac Life Sciences, Beijing, China) is currently undergoing its clinical trials in several countries and showing good results. We investigated the immune mechanisms underlying CoronaVac from the perspective of single-cell gene expressions and immune function features.Methods: In this controlled study, 13 healthy participants aged 21–54 years were recruited in the vaccination group and intramuscularly injected with two doses of CoronaVac (3 μg / 0·5 mL per dose, at Day00 and Day28, right after blood sampling), with peripheral blood samples collected at Day00, Day14, Day28, Day35, and Day45 to monitor dynamic changes. As positive control, 12 participants aged 28–75 years that had recovered from COVID-19 for approximately eight months were recruited in the recovery group with peripheral blood samples collected. Considering the high cost of sequencing, 11 samples from two healthy participants (H1 and H2) with four timepoints (Day00, Day14, Day28, and Day35) and three recovered participants (R1, R2, and R3) with one timepoint (Month8) were randomly chosen for single-cell RNA sequencing of peripheral blood mononuclear cells (PBMC). The transcriptomics of PBMC and its constituent cells were analyzed as gene expression responses. For samples from all 25 participants, the serum neutralizing antibody titer to live SARS-CoV-2 and the in vitro cytokine release activity of CD4+T cells were assayed as immune function responses.Findings: Single-cell RNA sequencing showed that the PBMC transcriptomics after vaccination resembled the COVID-19 recovery control more than that before vaccination, which also applied to its constituent cells such as B cells, T cells, NK cells, and myeloid cells. Gradual transitions of PBMC transcriptomics were observed from Day14 to Day28 and Day35 in vaccination groups, which finally approached the recovery control. The B cell levels in PBMC increased after each vaccination, while the T cell levels mainly increased within four weeks after the first vaccination and peaked at Day28. The serum neutralizing antibody titer to live SARS-CoV-2 was low within four weeks after the first vaccination, but the second vaccination could induce significantly higher serum neutralizing antibody titers due to the immune memory. For both vaccinated participants and recovered participants, the upregulated JUN/FOS network and tuned expressions of immunoglobulin fragments such as IGHV3-30 and IGLV2-23 were observed in B cells. By purifying CD4+T cells from PBMC and re-stimulating them with CoronaVac in vitro, five cytokines were significantly released, including Th1 cytokines (IFN-γ and IL-2) and Th2 cytokines (IL-4, IL-6, and IL-10). Th1 cytokines were mainly activated at Day14, Day28, and Day35, supporting cellular immune responses at early stages when the serum neutralizing antibody titer was low. Th2 cytokines were mainly activated at Day28, Day35, and Day45, supporting humoral immune responses at later stages, especially after the second vaccination.Interpretation: Two vaccinations of CoronaVac (3 µg per dose, with an interval of 28 days) could make positive gene expression and immune responses in healthy participants, as revealed by single-cell PBMC transcriptomics and immune function assays.Funding Statement: China's National Science and Technology Major Projects for Major New Drugs Innovation and Development.Declaration of Interests: QG, YH, XM, and SZ are employees of Sinovac Life Sciences, Beijing, China. The other authors declare no competing interests.Ethics Approval Statement: This study was approved by the Peking University Biomedical Ethics Committee.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
ZhangLU完成签到,获得积分10
1秒前
汉堡包的应助被xc采纳,获得10
2秒前
Eric的应助被zkl采纳,获得10
2秒前
3秒前
4秒前
念汐发布了新的文献求助10
5秒前
秋熙宸完成签到,获得积分10
6秒前
6秒前
等待的莹芝完成签到 ,获得积分10
6秒前
Jasper的应助被xx采纳,获得10
6秒前
旺旺完成签到 ,获得积分10
7秒前
7秒前
Jerry发布了新的文献求助10
7秒前
人谷完成签到 ,获得积分10
7秒前
bkagyin的应助被巴斯光年采纳,获得10
8秒前
大模型的应助被richardhipower采纳,获得10
8秒前
阿南发布了新的文献求助10
9秒前
十一一完成签到 ,获得积分10
9秒前
慕青的应助被哈哈哈采纳,获得10
9秒前
小蘑菇的应助被zkl采纳,获得10
11秒前
sln发布了新的文献求助10
11秒前
Yao发布了新的文献求助10
14秒前
15秒前
人谷呀完成签到 ,获得积分10
15秒前
TopBanana完成签到 ,获得积分10
17秒前
17秒前
Biu发布了新的文献求助10
18秒前
天天快乐的应助被xc采纳,获得10
18秒前
Xieyob关注了科研通微信公众号
19秒前
20秒前
香蕉觅云的应助被richardhipower采纳,获得10
20秒前
Sylvia卉完成签到,获得积分10
20秒前
酱油发布了新的文献求助10
22秒前
xsx发布了新的文献求助10
22秒前
虹虹完成签到 ,获得积分10
23秒前
领导范儿的应助被科研通管家采纳,获得10
23秒前
深情安青的应助被科研通管家采纳,获得10
23秒前
FashionBoy的应助被科研通管家采纳,获得10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189722
求助须知:如何正确求助?哪些是违规求助? 9576968
关于积分的说明 21850614
捐赠科研通 7787686
什么是DOI,文献DOI怎么找? 3435771
关于科研通互助平台的介绍 2559813
邀请新用户注册赠送积分活动 2482639